The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Hogan & Hartson’s Munich office has added a former Allen & Overy (A&O) corporate partner as part of its bid to launch a transatlantic life sciences practice.
Henning Mennenöh, who was at Clifford Chance prior to joining A&O, specialises in corporate and M&A work for pharmaceutical and biotechnology companies.
Mennenöh’s hire is part of a concerted effort by Hogan to target the European life sciences market. Mennenöh will join in December, prior to which the firm will have transferred key life sciences partner Linda Horton from Washington DC to Brussels.
Horton spent most of her career at the US Food and Drug Administration (FDA) before joining Hogan in 2002. She was the FDA’s legislative chief, deputy chief counsel and director of international policy. She now advises on FDA and European regulations.
Horton is hoping to export the firm’s flourishing life sciences practice to Europe and help clients devise transatlantic regulatory strategies. The firm has approximately 180 lawyers involved in its life sciences group, with around 20 in its European offices.